Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Th-POK Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP188078
Description
Th-POK Polyclonal specifically detects Th-POK in Human samples. It is validated for Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
Th-POK | |
Polyclonal | |
Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1 - 4 ug/ml, Immunohistochemistry-Paraffin 1:20-1:50 | |
hcKroxc-Krox, Krueppel-related zinc finger protein cKrox, kruppel-related zinc finger protein hcKrox, T-helper-inducing POZ/Krueppel-like factor, THPOK, ZBTB15zinc finger protein 67 homolog (mouse), zfp-67, ZFP67, zinc finger and BTB domain containing 15, zinc finger and BTB domain containing 7B, Zinc finger and BTB domain-containing protein 15, zinc finger and BTB domain-containing protein 7B, Zinc finger protein 67 homolog, Zinc finger protein 857B, Zinc finger protein Th-POK, ZNF857BDKFZp686G01254 | |
Rabbit | |
Affinity Purified | |
RUO | |
51043 | |
Human | |
IgG |
Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
Unconjugated | |
PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide | |
ZBTB7B | |
This antibody was developed against Recombinant Protein corresponding to amino acids:LLEFAYTATLTTSSANMPAVLQAARLLEIPCVIAACMEILQGSGLEAPSPDEDDCERARQYLEAFATATASGVPNGEDSPPQVPLPPPPPPPPRPVARRSRKPRKAFLQTKG | |
0.1 mL | |
Primary | |
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Th-POK Antibody, Novus Biologicals™ > 0.1mL; Unlabeled
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction